Invention Grant
- Patent Title: Antibodies binding AXL
-
Application No.: US16248402Application Date: 2019-01-15
-
Publication No.: US10765743B2Publication Date: 2020-09-08
- Inventor: Esther Breij , David Satijn , Edward Norbert Van Den Brink , Dennis Verzijl , Rob N. De Jong , Paul Parren , Riemke Van Dijkhuizen Radersma
- Applicant: GENMAB A/S
- Applicant Address: DK Copenhagen V
- Assignee: GENMAB A/S
- Current Assignee: GENMAB A/S
- Current Assignee Address: DK Copenhagen V
- Agency: Nelson Mullins Riley & Scarborough LLP
- Agent Jane E. Remillard, Esq.; Christopher L. Frank
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@cd027ea com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@462fcb0b com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@6655fe1b com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@46b0c4df
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/28 ; A61K47/68 ; A61K39/00 ; C07K16/30
Abstract:
The present invention relates to anti-AXL antibodies, immunoconjugates, compositions and method of treatment of cancer with such anti-AXL antibodies, immunoconjugates, or compositions.
Public/Granted literature
- US20190275149A1 ANTIBODIES BINDING AXL Public/Granted day:2019-09-12
Information query
